OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of PCIF1‐mediated 5′‐cap N6‐methyladeonsine mRNA methylation in colorectal cancer and anti‐PD‐1 immunotherapy
Lingling Wang, Lujing Wu, Zhouting Zhu, et al.
The EMBO Journal (2022) Vol. 42, Iss. 2
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Regulation and functions of non-m6A mRNA modifications
Hanxiao Sun, Kai Li, Cong Liu, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 10, pp. 714-731
Closed Access | Times Cited: 122

The epitranscriptional factor PCIF1 orchestrates CD8+ T cell ferroptosis and activation to control antitumor immunity
Bolin Xiang, Meiling Zhang, Kai Li, et al.
Nature Immunology (2025) Vol. 26, Iss. 2, pp. 252-264
Closed Access | Times Cited: 2

Roles and therapeutic implications of m6A modification in cancer immunotherapy
Juan Pan, Tuxiong Huang, Zhenjun Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21

Trinucleotide mRNA Cap Analogue N6-Benzylated at the Site of Posttranscriptional m6Am Mark Facilitates mRNA Purification and Confers Superior Translational Properties In Vitro and In Vivo
Marcin Warmiński, Edyta Trepkowska, Mirosław Śmietański, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 12, pp. 8149-8163
Open Access | Times Cited: 12

MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine
Elisa Martino, Nunzia D’Onofrio, Camilla Anastasio, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 371-384
Open Access | Times Cited: 15

Regulations of m6A and other RNA modifications and their roles in cancer
Xinhui Chen, Kunxiong Guo, Jing Li, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 4, pp. 622-648
Closed Access | Times Cited: 5

RNA modification m 6 Am: the role in cardiac biology
Daniel Benák, František Kolář, Lu Zhang, et al.
Epigenetics (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 15

N6-methyladenosine (m6A) in cancer stem cell: From molecular mechanisms to therapeutic implications
Liming Wang, Yuanxin Tang
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114846-114846
Open Access | Times Cited: 13

The CTBP2-PCIF1 complex regulates m6Am modification of mRNA in head and neck squamous cell carcinoma
Kang Li, Jie Chen, Caihua Zhang, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 20
Open Access | Times Cited: 12

m6Am methyltransferase PCIF1 negatively regulates ciliation by inhibiting BICD2 expression
Shanshan Xie, Wenjun Kuang, Mengzhe Guo, et al.
The Journal of Cell Biology (2024) Vol. 223, Iss. 6
Closed Access | Times Cited: 4

Regulation of m6Am RNA modification and its implications in human diseases
Hao Jin, Zhouyuanjing Shi, Tianhua Zhou, et al.
Journal of Molecular Cell Biology (2024) Vol. 16, Iss. 3
Open Access | Times Cited: 3

Integrative analysis of anoikis-related genes prognostic signature with immunotherapy and identification of CDKN3 as a key oncogene in lung adenocarcinoma
Haotian Qin, Qichang Wang, Juan Xu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113282-113282
Closed Access | Times Cited: 2

m6Am sequesters PCF11 to suppress premature termination and drive neuroblastoma differentiation
Huihui An, Yifan Hong, Yeek Teck Goh, et al.
Molecular Cell (2024) Vol. 84, Iss. 21, pp. 4142-4157.e14
Closed Access | Times Cited: 2

PCIF1, the only methyltransferase of N6,2-O-dimethyladenosine
Yuting Wu, Xi Pu, Sihui Wu, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5

Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy
Stefania Douka, Vasilis Papamoschou, Monica Raimo, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1143-1143
Open Access | Times Cited: 1

Microdroplet-enhanced chip platform for high-throughput immunotherapy marker screening from extracellular vesicle RNAs and membrane proteins
Chuanhao Tang, Zaizai Dong, Yan Shi, et al.
Biosensors and Bioelectronics (2024) Vol. 267, pp. 116748-116748
Closed Access | Times Cited: 1

Decoding m6Am by simultaneous transcription-start mapping and methylation quantification
Jianheng Liu, Ben R Hawley, L. V. B. Nicholson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Epigenetic regulation of epithelial–mesenchymal transition during cancer development
Sunisa Yoodee, Visith Thongboonkerd
International review of cell and molecular biology (2023), pp. 1-61
Closed Access | Times Cited: 2

Identification and verification of KEAP1‐related genes and targets regulated by potential ingredients in KRAS mutant colorectal cancer
Gang Wang, Fei Li, Zhi Min Zhu, et al.
Precision Medical Sciences (2024) Vol. 13, Iss. 3, pp. 148-166
Open Access

The potential of RNA methylation in the treatment of cardiovascular diseases
Kai Wang, Yuqin Wang, Yinghui Li, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110524-110524
Open Access

m6Am Methyltransferase PCIF1 Regulates Periodontal Inflammation
Wenqiang Song, Linfeng Liu, Liang Hao, et al.
Journal of Dental Research (2024)
Closed Access

Page 1 - Next Page

Scroll to top